Aspirin reduces the risk of cancer recurrence in prostate cancer patients, study suggests
Monday, May 2, 2011 - 10:30
in Health & Medicine
Some studies have shown that blood-thinning medications, such as aspirin, can reduce biochemical failure the risk of metastasis and even death in localized prostate cancer. These studies, although very telling, have all emphasized the need for more data. Now, with researchers having concluded the largest study on this topic, and there is substantial data suggesting that aspirin improves outcomes in prostate cancer patients who have received radiotherapy.